Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
fortune.com
A joint study between Yale University, King’s College Hospital in London and Doctors Without Borders found a single shot could be made for just 89 cents.

cross-posted from: https://mander.xyz/post/11304633

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

    • pearsaltchocolatebar@discuss.onlineEnglish
      0·
      3 months ago

      No medicines have copyrights, but they do have patents. And, drug patents are kinda necessary if you want money to be spent on developing new drugs.

      No one is going to dump a few hundred million into developing a new drug if everyone can manufacture and sell it upon release.

      Patents aren’t the issue, though, it’s companies charging out the ass because they can.

      • Sneezycat@sopuli.xyzEnglish
        0·
        3 months ago

        Publicly funded research is out of the question then? Why does it have to be private corporations doing the research?

        • lemming@sh.itjust.worksEnglish
          0·
          3 months ago

          A state doesn’t have this kind of money to burn. If they did it, the money would have to come from somewhere. So either you increase taxes, decrease spending elsewhere, or start a business making a lot of money. Such as, say, selling the newly developed medications at a markup… It’s sad, but I’m not aware of a better way.

          That being said, the cost of medications in the US is utterly ridiculous.

          • Risk@feddit.ukEnglish
            0·
            3 months ago

            Except as highlighted, if the drug didn’t make a return on investment it wouldn’t be made. That can be true for government funded research, it’s not necessary to have a profit margin on top.

            • Sneezycat@sopuli.xyzEnglish
              0·
              3 months ago

              To add to this, better drugs pay for themselves, because then public healthcare doesn’t need to pay for more ineffective treatments. Having fewer sick people also improves productivity and the economy.